DetallesGráficoPerfilMatriz de riesgoNoticiasDocumentos

Bellevue Biotech DT CHF/  CH0113817123  /

Fonds
NAV14/11/2024 Diferencia-53.2100 Tipo de beneficio Enfoque de la inversión Sociedad de fondos
3,725.9900CHF -1.41% reinvestment Equity Swisscanto Fondsl. ▶
     
Chart for Bellevue Biotech DT CHF
  Nombre   ISIN Performance Volatilidad Índice de Sharpe
1. Abaris Biotech.Opportunities A USD LU2210105313 +92.07% 39.60% 2.25
2. Abaris Biotech.Opportunities A CHF LU2210124454 +87.72% 39.59% 2.14
3. Janus Henderson Horizon Biotechnology Fund IU2 EUR LU2441282626 +44.52% 20.34% 2.04
4. Janus Henderson Horizon Biotechnology Fund A2 EUR LU2441282899 +44.28% 20.69% 1.99
5. HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD LU1540962054 +36.63% 17.29% 1.94
6. HBM Global Biotechnology Fund A cap USD LU1540961759 +36.28% 17.31% 1.92
7. Candriam Equities L Biotech.R USD Acc LU0942225912 +35.58% 17.00% 1.91
8. Candriam Equities L Biotech.I USD Acc LU0133360163 +34.18% 16.92% 1.84
9. Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse I (acc) USD LU0195948822 +38.00% 19.45% 1.80
10. Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) SGD LU0320765992 +36.67% 18.76% 1.79
...
76. Bellevue Biotech DT CHF CH0113817123 +19.59% 18.18% 0.91